Similarly, PI3K inhibitor GDC-0941 as single-agent or in combination with Olaparib also yielded growth inhibitory effects on ovarian cancer cell lines examined, except for EFO27 cells (Figure S4). This evidence concerns the gene PIK3CA and ovarian cancer.